Literature DB >> 29547896

Using pseudo-observations for estimation in relative survival.

Klemen Pavlič1, Maja Pohar Perme1.   

Abstract

A common goal in the analysis of the long-term survival related to a specific disease is to estimate a measure that is comparable between populations with different general population mortality. When cause of death is unavailable or unreliable, as for example in cancer registry studies, relative survival methodology is used-in addition to the mortality data of the patients, we use the data on the mortality of the general population. In this article, we focus on the marginal relative survival measure that summarizes the information about the disease-specific hazard. Under additional assumptions about latent times to death of each cause, this measure equals net survival. We propose a new approach to estimation based on pseudo-observations and derive two estimators of its variance. The properties of the new approach are assessed both theoretically and with simulations, showing practically no bias and a close to nominal coverage of the confidence intervals with the precise formula for the variance. The approximate formula for the variance has sufficiently good performance in large samples where the precise formula calculation becomes computationally intensive. Using bladder cancer data and simulations, we show that the behavior of the new approach is very close to that of the Pohar Perme estimator but has the important advantage of a simpler formula that does not require numerical integration and therefore lends itself more naturally to further extensions.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cancer survival; Excess hazards; Heterogeneity; Net survival; Pseudo-observations; Relative survival

Mesh:

Year:  2019        PMID: 29547896     DOI: 10.1093/biostatistics/kxy008

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  8 in total

1.  Integrating relative survival in multi-state models-a non-parametric approach.

Authors:  Damjan Manevski; Hein Putter; Maja Pohar Perme; Edouard F Bonneville; Johannes Schetelig; Liesbeth C de Wreede
Journal:  Stat Methods Med Res       Date:  2022-03-14       Impact factor: 2.494

2.  Correcting for misclassification and selection effects in estimating net survival in clinical trials.

Authors:  Juste Aristide Goungounga; Célia Touraine; Nathalie Grafféo; Roch Giorgi
Journal:  BMC Med Res Methodol       Date:  2019-05-16       Impact factor: 4.615

3.  Understanding disparities in cancer prognosis: An extension of mediation analysis to the relative survival framework.

Authors:  Elisavet Syriopoulou; Mark J Rutherford; Paul C Lambert
Journal:  Biom J       Date:  2020-12-14       Impact factor: 2.207

4.  Direct modelling of age standardized marginal relative survival through incorporation of time-dependent weights.

Authors:  Paul C Lambert; Elisavet Syriopoulou; Mark R Rutherford
Journal:  BMC Med Res Methodol       Date:  2021-04-24       Impact factor: 4.615

5.  Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.

Authors:  Elisavet Syriopoulou; Alessandro Gasparini; Keith Humphreys; Therese M-L Andersson
Journal:  Breast Cancer Res       Date:  2022-02-23       Impact factor: 6.466

6.  Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy.

Authors:  Yuliya Leontyeva; Hannah Bower; Oskar Gauffin; Paul C Lambert; Therese M-L Andersson
Journal:  BMC Med Res Methodol       Date:  2022-05-02       Impact factor: 4.615

7.  Direct modeling of the crude probability of cancer death and the number of life years lost due to cancer without the need of cause of death: a pseudo-observation approach in the relative survival setting.

Authors:  Dimitra-Kleio Kipourou; Maja Pohar Perme; Bernard Rachet; Aurelien Belot
Journal:  Biostatistics       Date:  2022-01-13       Impact factor: 5.899

8.  Marginal measures and causal effects using the relative survival framework.

Authors:  Elisavet Syriopoulou; Mark J Rutherford; Paul C Lambert
Journal:  Int J Epidemiol       Date:  2020-04-01       Impact factor: 7.196

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.